The day before announcing Zyn’s marketing authorization, FDA Center for Tobacco Products announced another proposed rule that could have a massive impact on public health: a product standard that ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ongoing clinical studies aimed at expanding its use beyond acute pain management.

Actavis Labs. FL, Inc. v. United States, Appeal No. 2023-1320 (Fed. Cir. Mar. 21, 2025) Our Case of the Week, in the words of ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...

The latest trend in treating hair loss may sound familiar: Essentially, it’s a repurposed drug first popularized in the 1990s.

The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

New medicines are being developed for individual treatments based on someone’s DNA. Those would be allowed under a proposed ...

Soon after Borzelleca's paper was published in a scientific journal, Food and Chemical Toxicology, the FDA examined the data his team had collected and reached its own conclusion: that the dye caused ...

And Texas, spurred by a crusading longtime former governor, has the upper hand in bringing Ibogaine to the United States.

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...